Board Meetings for NATCOPHARM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| NATCOPHARM | Natco Pharma Limited | 27 May 2019 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2019, dividend and other business matters | |
| NATCOPHARM | Natco Pharma Limited | 12 Feb 2019 | Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2018 and dividend | |
| NATCOPHARM | Natco Pharma Limited | 05 Nov 2018 | Financial Results/Buyback | To consider and approve the financial results for the period ended September 30, 2018 and buyback for equity shares | |
| NATCOPHARM | Natco Pharma Limited | 08 Aug 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended Jun 30, 2018 and dividend | |
| NATCOPHARM | Natco Pharma Limited | 23 May 2018 | Financial Results | To consider and approve the financial results for the period ended March 31, 2018 | |
| NATCOPHARM | Natco Pharma Limited | 06 Feb 2018 | Results/Dividend | To consider among others things, the following items of business: 1. The unaudited financial Results for the quarter and the nine months ended December 31, 2017 and related matters. 2. To consider second Interim Dividend, if any, for the financial year 2017-18 and related matters etc. | |
| NATCOPHARM | Natco Pharma Limited | 02 Nov 2017 | Results/Others | To consider, among other things, the following items of businesses and related matters: 1. Approval of the unaudited financial results, both on standalone and consolidated basis for the quarter and half-year ended September 30, 2017. 2. Approval for raising of funds through further issue of shares or convertible securities of any nature through one or more modes, including but not limited to a further public offer, rights issue, qualified institutions placement, issue of american depository receipts or global depository receipts etc. subject to such approvals as may be required. 3. Convening of Extraordinary General Meeting of the members of the Company to approve such raising of funds. | |
| NATCOPHARM | Natco Pharma Limited | 07 Aug 2017 | Results/Dividend | To consider, among other things, the following items of businesses and related matters: 1. Unaudited financial results for the quarter ended June 30, 2017 along with the Limited Review Report thereon. 2. To Consider Interim Dividend, if any, for the year 2017-18. 3. Convening of 34th Annual General Meeting to be held for the financial year 2016-17. 4. Consideration of Natco Employee Stock Option Scheme 2017 (NATSOP 2017) under SEBI (Share Based Employee Benefits) Regulations, 2014 | |
| NATCOPHARM | Natco Pharma Limited | 30 May 2017 | Results | Inter alia, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2017 and related matters. | |
| NATCOPHARM | Natco Pharma Limited | 14 Feb 2017 | Results/Dividend | To consider among other things, the following items of business: 1. The audited financial Results for the quarter ended December 31, 2016 and related matters. 2. To consider second Interim Dividend, if any, for the financial year 2016-17 and related matters etc. | |
| NATCOPHARM | Natco Pharma Limited | 11 Nov 2016 | Results | To consider among other things, the Unaudited Financial Results for the quarter and half year ended September 30, 2016 and related matters. | |
| NATCOPHARM | Natco Pharma Limited | 09 Aug 2016 | Results/Dividend | to consider among other things, the following items of business and related matters:1) Unaudited financial Results for the quarter ended June 30, 2016. 2) To consider Interim Dividend, if any, for the year 2016-17. 3) Convening of Annual General Meeting for the financial year 2015-16. 4) Consideration of Employee Stock Option scheme (NATSOP2016) under SEBI(Share Based Employee Benefits) regulations, 2014. | |
| NATCOPHARM | Natco Pharma Limited | 26 May 2016 | Results | To, inter alia, consider and approve the Audited Financial Results for the Year ended March 31, 2016. | |
| NATCOPHARM | Natco Pharma Limited | 11 Feb 2016 | Results/Dividend | to consider among other things, the following : 1) The unaudited financial Results for the quarter and nine months ended December 31, 2015 and related matters. 2) To consider Interim Dividend, if any, for the financial year 2015-16 and related matters etc. | |
| NATCOPHARM | Natco Pharma Limited | 13 Nov 2015 | Results/Others | to consider among other things, the following:1. The un-audited Results for the quarter and half year ended September 30, 2015 and other related matters.2. To fix record date for sub-division of 1 (One) Equity Share of face value of Rs. 10/- each into 5(five) Equity Shares of Rs. 2/- Each. |